VPC

Vestal Point Capital Portfolio holdings

AUM $1.9B
1-Year Return 12.28%
This Quarter Return
-7.05%
1 Year Return
-12.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.34B
AUM Growth
+$132M
Cap. Flow
+$239M
Cap. Flow %
17.84%
Top 10 Hldgs %
54.87%
Holding
79
New
21
Increased
28
Reduced
5
Closed
19

Top Buys

1
RARE icon
Ultragenyx Pharmaceutical
RARE
$69.5M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
$42.7M
3
EXAS icon
Exact Sciences
EXAS
$34.9M
4
ACLX icon
Arcellx
ACLX
$31.7M
5
ASND icon
Ascendis Pharma
ASND
$30.7M

Top Sells

1
NBIX icon
Neurocrine Biosciences
NBIX
$97.9M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
$52.3M
3
AZN icon
AstraZeneca
AZN
$27.1M
4
NARI
Inari Medical, Inc. Common Stock
NARI
$21.7M
5
ARGX icon
argenx
ARGX
$19.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VTYX icon
51
Ventyx Biosciences
VTYX
$185M
$3.04M 0.23%
+1,315,000
New +$3.04M
PTCT icon
52
PTC Therapeutics
PTCT
$4.61B
$2.75M 0.21%
+90,000
New +$2.75M
VERV
53
DELISTED
Verve Therapeutics
VERV
$2.44M 0.18%
+500,000
New +$2.44M
IOVA icon
54
Iovance Biotherapeutics
IOVA
$796M
$2.41M 0.18%
+300,000
New +$2.41M
PRME icon
55
Prime Medicine
PRME
$606M
$2.31M 0.17%
450,000
+90,000
+25% +$463K
CMRX
56
DELISTED
Chimerix, Inc.
CMRX
$1.23M 0.09%
1,400,000
– –
ACHL
57
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$1.22M 0.09%
1,500,000
– –
ATRA icon
58
Atara Biotherapeutics
ATRA
$89.9M
$952K 0.07%
112,000
– –
OKUR
59
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$36.4M
$823K 0.06%
54,500
+24,962
+85% +$377K
NAMS icon
60
NewAmsterdam Pharma
NAMS
$2.89B
$480K 0.04%
+25,000
New +$480K
AFMD
61
DELISTED
Affimed
AFMD
– –
-55,000
Closed -$292K
AGIO icon
62
Agios Pharmaceuticals
AGIO
$2.1B
– –
-325,000
Closed -$9.5M
ALNY icon
63
Alnylam Pharmaceuticals
ALNY
$59.4B
– –
-350,000
Closed -$52.3M
ARGX icon
64
argenx
ARGX
$44.9B
– –
-50,000
Closed -$19.7M
AZN icon
65
AstraZeneca
AZN
$254B
– –
-400,000
Closed -$27.1M
BIO icon
66
Bio-Rad Laboratories Class A
BIO
$7.83B
– –
-15,000
Closed -$5.19M
BMRN icon
67
BioMarin Pharmaceuticals
BMRN
$10.9B
– –
-175,000
Closed -$15.3M
GERN icon
68
Geron
GERN
$880M
– –
-2,200,000
Closed -$7.26M
INCY icon
69
Incyte
INCY
$16.7B
– –
-200,000
Closed -$11.4M
KRYS icon
70
Krystal Biotech
KRYS
$4.33B
– –
-45,000
Closed -$8.01M
LYEL icon
71
Lyell Immunopharma
LYEL
$225M
– –
-6,500
Closed -$290K
LYRA icon
72
Lyra Therapeutics
LYRA
$11.6M
– –
-16,000
Closed -$4.98M
NBIX icon
73
Neurocrine Biosciences
NBIX
$13.9B
– –
-710,000
Closed -$97.9M
NVAX icon
74
Novavax
NVAX
$1.27B
– –
-500,000
Closed -$2.39M
SRPT icon
75
Sarepta Therapeutics
SRPT
$1.93B
– –
-100,000
Closed -$12.9M
1 2
3
4